MF研究者総覧

教員活動データベース

Investigation of predictors of bleeding complications in COVID-19 using rotational thromboelastometry (ROTEM ®): A retrospective study

発表形態:
原著論文
主要業績:
主要業績
単著・共著:
共著
発表年月:
2022年05月
DOI:
10.1002/hsr2.655
会議属性:
指定なし
査読:
有り
リンク情報:

日本語フィールド

著者:
○Ayaka Matsuoka, Hiroyuki Koami, Kota Shinada, Akira Sasaki, Hirotaka Yamazaki, Kosuke Mori, Kento Nakayama, Miho Asahi, Kunimasa Yoshitake, Shogo Narumi, Mayuko Koba, Atsushi Kawaguchi, Yuichiro Sakamoto
題名:
Investigation of predictors of bleeding complications in COVID-19 using rotational thromboelastometry (ROTEM ®): A retrospective study
発表情報:
Health Sci Rep 巻: 5 号: 3 ページ: e655
キーワード:
anticoagulation; coagulopathy; point of care testing; prothrombin time
概要:
Background: Hemorrhagic complications in patients with coronavirus 19 disease (COVID-19) are infrequent but associated with a prognosis. This study aimed to elucidate the risk factors for bleeding complications in patients with COVID-19 using rotational thromboelastometry (ROTEM) parameters and blood tests performed at admission. Methods: In total, 31 patients with severe COVID-19 treated intensively at Saga University Hospital were included in this study. Patients were divided into two groups according to the presence or absence of hemorrhagic complications. Results from the blood tests performed at admission and during hospitalization, and ROTEM values acquired upon admission, were compared between the two groups. Results: There were significant differences in ROTEM values upon admission between the bleeding and non-bleeding groups. Receiver operating curve analysis showed that the area under the curve for prothrombin time international normalized ratio (PT-INR) and extrinsically-activated test with tissue factor (EXTEM) amplitude at 10 min (A10) were 0.82 (0.52-0.92) and 0.81 (0.58-0.93), respectively. Logistic regression analysis with PT-INR and EXTEM A10 as factors calculated an odds ratio of 1.94 (1.04-3.62) and EXTEM A10 0.86 (0.71-1.05) for bleeding complications occurrence. Conclusion: ROTEM may be a sensitive predictor for bleeding complications in patients with COVID-19.
抄録:

英語フィールド

Author:
○Ayaka Matsuoka, Hiroyuki Koami, Kota Shinada, Akira Sasaki, Hirotaka Yamazaki, Kosuke Mori, Kento Nakayama, Miho Asahi, Kunimasa Yoshitake, Shogo Narumi, Mayuko Koba, Atsushi Kawaguchi, Yuichiro Sakamoto
Title:
Investigation of predictors of bleeding complications in COVID-19 using rotational thromboelastometry (ROTEM ®): A retrospective study
Announcement information:
Health Sci Rep Vol: 5 Issue: 3 Page: e655
Keyword:
anticoagulation; coagulopathy; point of care testing; prothrombin time
An abstract:
Background: Hemorrhagic complications in patients with coronavirus 19 disease (COVID-19) are infrequent but associated with a prognosis. This study aimed to elucidate the risk factors for bleeding complications in patients with COVID-19 using rotational thromboelastometry (ROTEM) parameters and blood tests performed at admission. Methods: In total, 31 patients with severe COVID-19 treated intensively at Saga University Hospital were included in this study. Patients were divided into two groups according to the presence or absence of hemorrhagic complications. Results from the blood tests performed at admission and during hospitalization, and ROTEM values acquired upon admission, were compared between the two groups. Results: There were significant differences in ROTEM values upon admission between the bleeding and non-bleeding groups. Receiver operating curve analysis showed that the area under the curve for prothrombin time international normalized ratio (PT-INR) and extrinsically-activated test with tissue factor (EXTEM) amplitude at 10 min (A10) were 0.82 (0.52-0.92) and 0.81 (0.58-0.93), respectively. Logistic regression analysis with PT-INR and EXTEM A10 as factors calculated an odds ratio of 1.94 (1.04-3.62) and EXTEM A10 0.86 (0.71-1.05) for bleeding complications occurrence. Conclusion: ROTEM may be a sensitive predictor for bleeding complications in patients with COVID-19.


Copyright © MEDIA FUSION Co.,Ltd. All rights reserved.